Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Specific immunotherapies in the treatment of cancers].
Denis H, Davoine C, Bermudez E, Grosjean G, Schwager M, Ifrah N, Dahan M, Negellen S. Denis H, et al. Among authors: ifrah n. Bull Cancer. 2019 Jan;106(1):37-47. doi: 10.1016/j.bulcan.2018.12.007. Epub 2019 Jan 11. Bull Cancer. 2019. PMID: 30638899 Review. French.
Breast cancer screening: Impact on care pathways.
Lefeuvre D, Catajar N, Le Bihan Benjamin C, Ifrah N, De Bels F, Viguier J, Bousquet PJ. Lefeuvre D, et al. Among authors: ifrah n. Cancer Med. 2019 Jul;8(8):4070-4078. doi: 10.1002/cam4.2283. Epub 2019 Jun 6. Cancer Med. 2019. PMID: 31172693 Free PMC article.
Editorial.
Ifrah N. Ifrah N. Cancer Radiother. 2022 Feb-Apr;26(1-2):1. doi: 10.1016/j.canrad.2021.08.008. Epub 2021 Dec 22. Cancer Radiother. 2022. PMID: 34953700 No abstract available.
Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.
Smith C, Touzart A, Simonin M, Tran-Quang C, Hypolite G, Latiri M, Andrieu GP, Balducci E, Dourthe MÉ, Goyal A, Huguet F, Petit A, Ifrah N, Baruchel A, Dombret H, Macintyre E, Plass C, Ghysdael J, Boissel N, Asnafi V. Smith C, et al. Among authors: ifrah n. Mol Cancer. 2023 Jan 18;22(1):12. doi: 10.1186/s12943-022-01701-x. Mol Cancer. 2023. PMID: 36650499 Free PMC article.
Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell Leukemia.
Trinquand A, Dos Santos NR, Tran Quang C, Rocchetti F, Zaniboni B, Belhocine M, Da Costa de Jesus C, Lhermitte L, Tesio M, Dussiot M, Cosset FL, Verhoeyen E, Pflumio F, Ifrah N, Dombret H, Spicuglia S, Chatenoud L, Gross DA, Hermine O, Macintyre E, Ghysdael J, Asnafi V. Trinquand A, et al. Among authors: ifrah n. Cancer Discov. 2016 Sep;6(9):972-85. doi: 10.1158/2159-8290.CD-15-0675. Epub 2016 Jun 28. Cancer Discov. 2016. PMID: 27354269
Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL.
Touzart A, Lengliné E, Latiri M, Belhocine M, Smith C, Thomas X, Spicuglia S, Puthier D, Pflumio F, Leguay T, Graux C, Chalandon Y, Huguet F, Leprêtre S, Ifrah N, Dombret H, Macintyre E, Hunault M, Boissel N, Asnafi V. Touzart A, et al. Among authors: ifrah n. Clin Cancer Res. 2019 Apr 15;25(8):2483-2493. doi: 10.1158/1078-0432.CCR-18-1844. Epub 2019 Jan 18. Clin Cancer Res. 2019. PMID: 30659025
[No title available]
[No authors listed] [No authors listed] PMID: 33843338
302 results